Patents by Inventor Warren Jaye Porter

Warren Jaye Porter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 6-substituted-3-1,3-benzothiazol-2-one compounds as TARP-gamma 8 dependent AMPA receptor antagonists
    Patent number: 9469632
    Abstract: A TARP ?8 dependant AMPA receptor antagonist of the formula: wherein X is CH or N; A is and R1 is as defined herein; its pharmaceutically acceptable salts, uses, and methods for its preparation are described.
    Type: Grant
    Filed: May 21, 2015
    Date of Patent: October 18, 2016
    Assignee: Eli Lilly and Company
    Inventors: Kevin Matthew Gardinier, Douglas Linn Gernert, Patric James Hahn, Sean Patrick Hollinshead, Albert Khilevich, Daniel Ray Mayhugh, Paul Leslie Ornstein, Warren Jaye Porter, Jon Kevin Reel, Jeffrey Michael Schkeryantz, Patrick Gianpietro Spinazze, Freddie Craig Stevens, Jeffrey Michael Witkin
  • 6-SUBSTITUTED-3H-1,3-BENZOTHIAZOL-2-ONE COMPOUNDS AS TARP-GAMMA 8 DEPENDENT AMPA RECEPTOR ANTAGONISTS
    Publication number: 20150344468
    Abstract: A TARP ?8 dependant AMPA receptor antagonist of the formula: wherein X is CH or N; A is and R1 is as defined herein; its pharmaceutically acceptable salts, uses, and methods for its preparation are described.
    Type: Application
    Filed: May 21, 2015
    Publication date: December 3, 2015
    Inventors: Kevin Matthew GARDINIER, Douglas Linn GERNERT, Patric James HAHN, Sean Patrick HOLLINSHEAD, Albert KHILEVICH, Daniel Ray MAYHUGH, Paul Leslie ORNSTEIN, Warren Jaye PORTER, Jon Kevin REEL, Jeffrey Michael SCHKERYANTZ, Patrick Gianpietro SPINAZZE, Freddie Craig STEVENS, Jeffrey Michael WITKIN
  • Tetrahydropyrrolothiazine compounds
    Patent number: 8889856
    Abstract: The present invention provides compounds of Formula I: wherein A is selected from the group consisting of; R1 is H or F; R2 is H, —CH2OH, C1-C3 alkyl, R3 is H, F, or CN; R4 is H, F; or CN; and R5 is H, —CH3, or —OCH3; or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: May 22, 2014
    Date of Patent: November 18, 2014
    Assignee: Eli Lilly and Company
    Inventors: James Peter Beck, Steven James Green, Jose Eduardo Lopez, Brian Michael Mathes, Dustin James Mergott, Warren Jaye Porter, Zoran Rankovic, Yuan Shi, Brian Morgan Watson, Leonard Larry Winneroski, Jr.
  • TETRAHYDROPYRROLOTHIAZINE COMPOUNDS
    Publication number: 20140256933
    Abstract: The present invention provides compounds of Formula I: wherein A is selected from the group consisting of; R1 is H or F; R2 is H, —CH2OH, C1-C3 alkyl, R3 is H, F, or CN; R4 is H, F; or CN; and R5 is H, —CH3, or —OCH3; or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 22, 2014
    Publication date: September 11, 2014
    Applicant: Eli Lilly and Company
    Inventors: James Peter BECK, Steven James GREEN, Jose Eduardo LOPEZ, Brian Michael MATHES, Dustin James MERGOTT, Warren Jaye PORTER, Zoran RANKOVIC, Yuan SHI, Brian Morgan WATSON, Leonard Larry WINNEROSKI, JR.
  • Tetrahydropyrrolothiazine compounds
    Patent number: 8772282
    Abstract: The present invention provides compounds of Formula I: wherein A is selected from the group consisting of; R1 is H or F; R2 is H, —CH2OH, C1-C3 alkyl, R3 is H, F, or CN; R4 is H, F; or CN; and R5 is H, —CH3, or —OCH3; or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: December 4, 2013
    Date of Patent: July 8, 2014
    Assignee: Eli Lilly and Company
    Inventors: James Peter Beck, Steven James Green, Jose Eduardo Lopez, Brian Michael Mathes, Dustin James Mergott, Warren Jaye Porter, Zoran Rankovic, Yuan Shi, Brian Morgan Watson, Leonard Larry Winneroski, Jr.
  • 6-((S)-1- {1-[5-(2-hydroxy-ethoxy)-pyridin-2-yl]-1H-pyrazol-3-YL}-ethyl)-3H-1,3-benzothiazol-2-one as a tarp-gamma 8 dependent AMPA receptor antagonist
    Patent number: 8765960
    Abstract: A TARP ?8 dependant AMPA receptor antagonist of the formula: its pharmaceutically acceptable salts, uses, and methods for its preparation are described.
    Type: Grant
    Filed: November 20, 2013
    Date of Patent: July 1, 2014
    Assignee: Eli Lilly and Company
    Inventors: Jon Kevin Reel, Warren Jaye Porter
  • 6-((S)-1--ETHYL)-3H-1,3-BENZOTHIAZOL-2-ONE AS A TARP-GAMMA 8 DEPENDENT AMPA RECEPTOR ANTAGONIST
    Publication number: 20140148441
    Abstract: A TARP ?8 dependant AMPA receptor antagonist of the formula: its pharmaceutically acceptable salts, uses, and methods for its preparation are described.
    Type: Application
    Filed: November 20, 2013
    Publication date: May 29, 2014
    Applicant: Eli Lilly and Company
    Inventors: Jon Kevin REEL, Warren Jaye PORTER
  • TETRAHYDROPYRROLOTHIAZINE COMPOUNDS
    Publication number: 20140094454
    Abstract: The present invention provides compounds of Formula I: wherein A is selected from the group consisting of; R1 is H or F; R2 is H, —CH2OH, C1-C3 alkyl, R3 is H, F, or CN; R4 is H, F; or CN; and R5 is H, —CH3, or —OCH3; or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 4, 2013
    Publication date: April 3, 2014
    Applicant: Eli Lilly and Company
    Inventors: James Peter BECK, Steven James GREEN, Jose Eduardo LOPEZ, Brian Michael MATHES, Dustin James MERGOTT, Warren Jaye PORTER, Zoran RANKOVIC, Yuan SHI, Brian Morgan WATSON, Leonard Larry WINNEROSKI, JR.
  • TETRAHYDROPYRROLOTHIAZINE COMPOUNDS
    Publication number: 20130261111
    Abstract: The present invention provides compounds of Formula I: wherein A is selected from the group consisting of; R1 is H or F; R2 is H, —CH2OH, C1-C3 alkyl, R3 is H, F, or CN; R4 is H, F; or CN; and R5 is H, —CH3, or —OCH3; or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 27, 2013
    Publication date: October 3, 2013
    Applicant: Eli Lilly and Company
    Inventors: James Peter BECK, Steven James GREEN, Jose Eduardo LOPEZ, Brian Michael MATHES, Dustin James MERGOTT, Warren Jaye PORTER, Zoran RANKOVIC, Yuan SHI, Brian Morgan WATSON, Leonard Larry WINNEROSKI, JR
  • Azepine derivatives as gamma-secretase inhibitors
    Patent number: 8188069
    Abstract: Compounds of formula (I), pharmaceutical compositions comprising them, and methods for their use are described.
    Type: Grant
    Filed: August 4, 2008
    Date of Patent: May 29, 2012
    Assignee: Eli Lilly and Company
    Inventors: Melinda Joy Hope Miller, Warren Jaye Porter, Jon Kevin Reel, Almudena Rubio-Esteban
  • AZEPINE DERIVATIVES AS GAMMA-SECRETASE INHIBITORS
    Publication number: 20100197660
    Abstract: Compounds of formula (I), pharmaceutical compositions comprising them, and methods for their use are described.
    Type: Application
    Filed: August 4, 2008
    Publication date: August 5, 2010
    Applicant: ELI LILLY AND COMPANY
    Inventors: Melinda Joy Hope Miller, Warren Jaye Porter, Jon Kevin Reel, Almudena Rubio-Esteban
  • DETECTING SOLUBLE A-BETA
    Publication number: 20090162280
    Abstract: Agents, methods, and kits for qualitatively or quantitatively determining the presence of soluble A-beta in source of A-beta are provided, wherein the agents comprise the compound of formula III or the compound of formula III labeled with a signal generator.
    Type: Application
    Filed: December 20, 2007
    Publication date: June 25, 2009
    Applicant: GENERAL ELECTRIC COMPANY
    Inventors: Cristina Abucay Tan Hehir, Tiberiu Mircea Siclovan, Tunchiao Hubert Lam, Michael Christopher Montalto, Richard Waltz Harper, Warren Jaye Porter